Recursion Pharmaceuticals Inc. (RXRX): Price and Financial Metrics

Recursion Pharmaceuticals Inc. (RXRX): $6.40

0.08 (+1.27%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

RXRX Price/Volume Stats

Current price $6.40 52-week high $15.74
Prev. close $6.32 52-week low $5.03
Day low $6.34 Volume 3,630,400
Day high $6.58 Avg. volume 5,674,126
50-day MA $6.64 Dividend yield N/A
200-day MA $8.54 Market Cap 1.80B

RXRX Stock Price Chart Interactive Chart >


Recursion Pharmaceuticals Inc. (RXRX) Company Bio


Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people’s lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.


RXRX Latest News Stream


Event/Time News Detail
Loading, please wait...

RXRX Latest Social Stream


Loading social stream, please wait...

View Full RXRX Social Stream

RXRX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!